Eli Lilly currently holds a patent on both drugs through 2036.
FDA receives applications for generic Mounjaro, Zepbound
Welcome to LJ News Opinions, where breaking news stories have captivated us for over 20 years.
Join us in this journey of sharing points of view about the news – read, react, engage, and unleash your opinion!